Does One Size Fit All? - Refining Parenteral Anticoagulant Therapy According to Body Weight. [PDF]
Furtado RHM.
europepmc +1 more source
Profilaxis de la enfermedad tromboembólica venosa con enoxaparina en el paciente quirúrgico
Actualmente las heparinas de bajo peso molecular constituyen el fármaco de elección en la profilaxis de la enfermedad tromboembólica venosa en el paciente quirúrgico, debido a características como su adecuada vida media y biodisponibilidad, administración en monodosis diaria por vía subcutánea, gran eficacia antitrombótica y sin necesidad de control de
Méndez Mora, J.L. +7 more
openaire +2 more sources
Influence of Obesity on the Safety and Efficacy of Antithrombotic Therapy: A Systematic Review and Meta-Analysis. [PDF]
Darzé BR +4 more
europepmc +1 more source
Clinical experience of prophylactic enoxaparin dosage adjustment guided by AntiXa factor levels in critical care patients with COVID-19-induced pneumonia: observational study. [PDF]
Bermúdez-Ruiz MDC +5 more
europepmc +1 more source
[Superficial venous thrombosis, a necessary image]. [PDF]
Morena López D +2 more
europepmc +1 more source
[Renal infaction in a patient with COVID-19]. [PDF]
Cuevas Tascón G +10 more
europepmc +1 more source
[Foot color change after COVID19]. [PDF]
Aguilar-Shea AL +3 more
europepmc +1 more source
Un anciano con ampollas hemorrágicas a distancia por enoxaparina
Elena González-Guerra +1 more
openaire +1 more source
Challenges of extended venous thromboembolism prophylaxis in medical and surgical patients. [PDF]
Chindamo MC +4 more
europepmc +1 more source

